Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Read UMR's Statement on the House Appropriations Committee's Passage of FY23 Labor-HHS Funding Bill
NIH's Role In Sustaining the U.S. Economy | 2022 Update Now Available

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

We Can Thank This Researcher with Type 1 Diabetes for the COVID-19 Vaccines

Dr. Drew Weissman at the University of Pennsylvania isn’t one to seek the spotlight. But as one of the two key researchers behind the science used to develop the first COVID-19 vaccines, his name has leapt into public view as of late 2020. Self-described as “just a basic scientist‚” Weissman is a modest man who has spent his lifetime devoted to research. He also happens to be living with type 1 diabetes (T1D) for more than 50 years, spanning the 2 decades that he and his colleagues have spent digging into the vaccine-related research that’s become so critical to public health at the moment.